IL132145A - Compositions for treating inflammatory bowel disease and uses thereof - Google Patents

Compositions for treating inflammatory bowel disease and uses thereof

Info

Publication number
IL132145A
IL132145A IL13214598A IL13214598A IL132145A IL 132145 A IL132145 A IL 132145A IL 13214598 A IL13214598 A IL 13214598A IL 13214598 A IL13214598 A IL 13214598A IL 132145 A IL132145 A IL 132145A
Authority
IL
Israel
Prior art keywords
compositions
inflammatory bowel
bowel disease
treating inflammatory
treating
Prior art date
Application number
IL13214598A
Other languages
English (en)
Other versions
IL132145A0 (en
Original Assignee
Borody Thomas J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO5940A external-priority patent/AUPO594097A0/en
Priority claimed from AUPO9785A external-priority patent/AUPO978597A0/en
Application filed by Borody Thomas J filed Critical Borody Thomas J
Publication of IL132145A0 publication Critical patent/IL132145A0/xx
Publication of IL132145A publication Critical patent/IL132145A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13214598A 1997-04-01 1998-04-01 Compositions for treating inflammatory bowel disease and uses thereof IL132145A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO5940A AUPO594097A0 (en) 1997-04-01 1997-04-01 Novel methods of treating inflammatory bowel disease
AUPO9785A AUPO978597A0 (en) 1997-10-14 1997-10-14 Methods of treating inflammatory bowel disease
PCT/AU1998/000222 WO1998043667A1 (en) 1997-04-01 1998-04-01 Methods and compositions for treating inflammatory bowel disease

Publications (2)

Publication Number Publication Date
IL132145A0 IL132145A0 (en) 2001-03-19
IL132145A true IL132145A (en) 2005-11-20

Family

ID=25645389

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13214598A IL132145A (en) 1997-04-01 1998-04-01 Compositions for treating inflammatory bowel disease and uses thereof

Country Status (16)

Country Link
US (1) US6277836B1 (de)
EP (1) EP0971735B1 (de)
JP (3) JP2001524951A (de)
AR (1) AR012304A1 (de)
AT (1) ATE389417T1 (de)
CA (1) CA2285923C (de)
CY (1) CY1109783T1 (de)
DE (1) DE69839261T2 (de)
DK (1) DK0971735T3 (de)
ES (1) ES2303351T3 (de)
IL (1) IL132145A (de)
NO (1) NO325947B1 (de)
NZ (1) NZ500696A (de)
PT (1) PT971735E (de)
SI (1) SI0971735T1 (de)
WO (1) WO1998043667A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551632B2 (en) * 1997-04-01 2003-04-22 Thomas Julius Borody Methods and compositions for treating inflammatory bowel disease
AUPP325398A0 (en) * 1998-04-30 1998-05-21 Borody, Thomas J. Improved method for eradicating h. pylori
ATE446767T1 (de) * 1999-02-12 2009-11-15 Univ Washington Gm-csf zur behandlung von morbus crohn
JP4803935B2 (ja) * 1999-10-08 2011-10-26 アフィニアム・ファーマシューティカルズ・インコーポレイテッド Ｆａｂｉ阻害剤
JP3369535B2 (ja) 1999-11-09 2003-01-20 松下電器産業株式会社 プラズマディスプレイ装置
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
KR20030011797A (ko) * 2000-03-28 2003-02-11 바이오케미 게젤샤프트 엠베하 맛이 차폐된 과립형 입자
AU2001285311B2 (en) 2000-08-29 2005-09-15 Biocon, Ltd Immunoregulatory compounds, derivatives thereof and their use
EP1560584B1 (de) * 2001-04-06 2009-01-14 Affinium Pharmaceuticals, Inc. Fab-i-inhibitoren
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US20030118329A1 (en) * 2001-12-21 2003-06-26 Pere Obrador Video indexing using high resolution still images
AUPS088702A0 (en) 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
JP4880448B2 (ja) 2003-03-17 2012-02-22 アフィナム ファーマシューティカルズ，インコーポレーテッド 複数の抗生物質を含む組成物、及びそれを用いる方法
US6930093B2 (en) * 2003-07-10 2005-08-16 Valeant Research & Development Use of ribofuranose derivatives against inflammatory bowel diseases
WO2005046567A2 (en) * 2003-09-10 2005-05-26 Meena Shelgaonkar Synergistic formulation of antioxidants and antimycobacterial agents: a method of making the same
WO2005072113A2 (en) * 2004-01-20 2005-08-11 Harty Richard F Compositions and methods of treatment for inflammatory diseases
EP1720536B1 (de) 2004-02-06 2012-04-25 PHARMATEL (R&D) PTY LIMITED as Trustee for the PHARMATEL (R & D) TRUST Verwendung von aminosalicylaten beim reizdarmsyndrom mit durchfall als vorherrschendem symptom
JP5009152B2 (ja) * 2004-05-28 2012-08-22 サリックス ファーマシューティカルズ， インコーポレイテッド 放射線誘発性腸炎の予防、処置、および回復
WO2007053131A2 (en) 2004-06-04 2007-05-10 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as antibiotic agents
ES2565848T3 (es) 2004-07-07 2016-04-07 Biocon Limited Síntesis de compuestos inmunorreguladores unidos por grupos azoicos
EP2586427A3 (de) * 2005-08-24 2013-05-29 Salix Pharmaceuticals, Inc. Balsazidformulierungen und Herstellung und Verwendung davon
US7452872B2 (en) * 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
CA2531261A1 (en) * 2005-12-21 2007-06-21 Institut Pasteur Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
CA2658506C (en) 2006-07-20 2016-01-26 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab 1 inhibitors
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US8436051B2 (en) 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US20090098088A1 (en) * 2007-10-10 2009-04-16 The Procter & Gamble Company Methods And Kits For The Treatment Of Diverticular Conditions
JP2011500552A (ja) * 2007-10-10 2011-01-06 ルピン・リミテッド 胃腸障害を処置するための医薬用組み合わせおよび組成物
WO2009064953A1 (en) * 2007-11-15 2009-05-22 Enanta Pharmaceuticals, Inc. Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases
EP2247291B1 (de) * 2008-02-08 2018-12-05 Red Hill Biopharma Ltd. Verfahren und zusammensetzungen zur behandlung von entzündlicher darmerkrankung
AU2009243066A1 (en) * 2008-05-01 2009-11-05 The Procter & Gamble Company Methods and kits for the treatment of inflammatory bowel disorder conditions
US20110082120A1 (en) * 2009-10-05 2011-04-07 Milne Jill C Substituted thioacetic acid salicylate derivatives and their uses
WO2011050397A1 (en) * 2009-10-26 2011-05-05 Borody Thomas J Novel enteric combination therapy
US8497256B2 (en) 2010-04-26 2013-07-30 Salix Pharmaceuticals, Ltd Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
BR112013014827A2 (pt) 2010-12-13 2016-10-04 Antony Wettstein formulações gástricas e colônicas e métodos para produzir e usar as mesmas
TWI573590B (zh) 2011-09-20 2017-03-11 雷希爾生藥有限公司 治療自體免疫疾病之組成物及方法
KR101720885B1 (ko) 2012-06-19 2017-03-28 데비오팜 인터네셔날 에스 에이 (e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
WO2014016671A2 (en) 2012-07-27 2014-01-30 Redhill Biopharma Ltd. Formulations and methods of manufacturing formulations for use in colonic evacuation
CA2953110C (en) 2014-05-22 2018-10-30 John Todd Kuenstner Treatment of diseases caused by mycobacterium avium using a combination of ultraviolet blood irradiation and antibiotics
LT3419628T (lt) 2016-02-26 2021-01-25 Debiopharm International Sa Medikamentas diabetinėms pėdų infekcijoms gydyti
AU2021298936A1 (en) 2020-06-30 2023-01-19 Redhill Biopharma Ltd. Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440763A (en) * 1981-03-18 1984-04-03 Block Drug Company, Inc. Use of 4-aminosalicyclic acid as an anti-inflammatory agent
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions

Also Published As

Publication number Publication date
NO325947B1 (no) 2008-08-25
IL132145A0 (en) 2001-03-19
CA2285923A1 (en) 1998-10-08
EP0971735A1 (de) 2000-01-19
CA2285923C (en) 2013-03-12
ES2303351T3 (es) 2008-08-01
NZ500696A (en) 2002-05-31
PT971735E (pt) 2008-06-02
JP2012126736A (ja) 2012-07-05
WO1998043667A1 (en) 1998-10-08
NO994778D0 (no) 1999-09-30
ATE389417T1 (de) 2008-04-15
JP2008024713A (ja) 2008-02-07
CY1109783T1 (el) 2013-09-04
JP2001524951A (ja) 2001-12-04
EP0971735B1 (de) 2008-03-19
EP0971735A4 (de) 2004-02-25
DK0971735T3 (da) 2008-07-07
DE69839261D1 (de) 2008-04-30
NO994778L (no) 1999-11-30
DE69839261T2 (de) 2009-03-26
AR012304A1 (es) 2000-10-18
SI0971735T1 (sl) 2008-08-31
US6277836B1 (en) 2001-08-21

Similar Documents

Publication Publication Date Title
IL132145A (en) Compositions for treating inflammatory bowel disease and uses thereof
GR3036364T3 (en) Compositions and methods for treating or preventing inflammatory diseases
ZA98454B (en) Personal cleansing compositions
PL336840A1 (en) Hair-care composition
EP0766564A4 (de) Kontrollierte freisetzung von polypeptidzusammensetzungen und methoden der behandlung von entzündlichen erkrankungen der eingeweide
PL335870A1 (en) Hair-care composition
IL127636A0 (en) Polyester compositions
HK1031174A1 (en) Compositions and methods for treating diabetes
EP0964032A4 (de) Neue zusammensetzung und behandlungsmittel
EP1020194A4 (de) Öl/wasser emulsion zusammenstellungen
BG105437A (en) REFLECTIVELY MODIFIED COMPOSITIONS AND METHODS FOR OBTAINING THEM
HUP0103562A3 (en) Novel compositions and use
ZA98455B (en) Personal cleansing compositions
PL336349A1 (en) Compositions for and methods for treating and diagnosing the mastocarcinoma
ZA988920B (en) Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
AU6386499A (en) Method and composition for treatment of inflammatory bowel disease
GB9806537D0 (en) Polyester compositions
IL120488A0 (en) Modifiers for water-setting inorganic compositions and modified water-setting inorganic compositions
HUP0400922A3 (en) Detergent compositions and their use
PL330353A1 (en) Detergent hair-care compositions and their application
GB9824450D0 (en) Malodour counteractant compositions
ZA982645B (en) Methods and compositions for treating inflammatory bowel disease
GB9901577D0 (en) Polyester compositions
PL342253A1 (en) Pharmacological compositions based on bibapticide for visualising and treating thrombuses
GB9725346D0 (en) Pharmaceutical composition for the treatment of inflammatory bowel disease

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired